Compare Illumina, Inc. (ILMN) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Global X Defense Tech ETF — how do they compare? Illumina, Inc. trades at $189.78 (market cap $27.94B), while Global X Defense Tech ETF trades at $60.55. The key difference: Illumina, Inc. is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| ILMN | SHLD | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $194.33 | $78.02 |
52-Week Low | $91.00 | $58.20 |
Enterprise Value | $29.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
SHLD trades at $60.03, down 0.05% on the day, with technical indicators showing a bearish trend from moving averages but neutral oscillators. The ETF focuses on global defense technology, benefiting from rising military budgets and geopolitical tensions. Recent news highlights institutional interest, including Decker Wealth Management's new position in Q1 2026, and analyst discussions on defense ETF comparisons amid sector tailwinds.
The outlook for SHLD is supported by structural growth in defense spending, but risks include political uncertainty and valuation concerns. Investors gain diversified exposure to defense tech innovation, though competition from other ETFs and expense ratios may impact relative performance. Near-term price action hinges on technical support at $59 and broader market sentiment toward defense stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
